[
  {
    "title": "康龙化成减持凶猛",
    "href": "http://stock.jrj.com.cn/2022/12/21202437229444.shtml",
    "datetime": "2022-12-21 20:24:04",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：信中康成和信中龙成已累计减持1.05%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/20174137226086.shtml",
    "datetime": "2022-12-20 17:41:07",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：信中康成、信中龙成减持期过半 已合计减持1.01%股份",
    "href": "http://stock.jrj.com.cn/2022/12/15165637215388.shtml",
    "datetime": "2022-12-15 16:56:47",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：宁波大分子公司筹划股权融资不超3亿美元",
    "href": "http://stock.jrj.com.cn/2022/11/29180137175098.shtml",
    "datetime": "2022-11-29 18:01:57",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达及其一致行动人完成减持合计2%股份",
    "href": "http://stock.jrj.com.cn/2022/11/21154637154172.shtml",
    "datetime": "2022-11-21 15:46:10",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人方面减持量过半 累计减持1.38%股份",
    "href": "http://stock.jrj.com.cn/2022/11/09174737124681.shtml",
    "datetime": "2022-11-09 17:47:05",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：信中康成方面减持比例达1.02%",
    "href": "http://stock.jrj.com.cn/2022/11/02155837106554.shtml",
    "datetime": "2022-11-02 15:58:05",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：第三季度净利3.76亿元，同比下降20.95%",
    "href": "http://stock.jrj.com.cn/2022/10/27214737091594.shtml",
    "datetime": "2022-10-27 21:47:06",
    "code": "300759"
  },
  {
    "title": "港股异动 | 康龙化成大跌超12% 4日连跌26%",
    "href": "http://stock.jrj.com.cn/2022/10/24155037077997.shtml",
    "datetime": "2022-10-24 15:50:43",
    "code": "300759"
  },
  {
    "title": "康龙化成2名实际控制人合计质押258万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2022/09/27185237025585.shtml",
    "datetime": "2022-09-27 18:52:12",
    "code": "300759"
  },
  {
    "title": "【互动】康龙化成：尚未了解到更多关于美国生物法案的细节 业务没有受到相关消息的影响",
    "href": "http://stock.jrj.com.cn/2022/09/13143936990970.shtml",
    "datetime": "2022-09-13 14:39:02",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人之一楼小强质押195万股",
    "href": "http://stock.jrj.com.cn/2022/09/01201836964146.shtml",
    "datetime": "2022-09-01 20:18:02",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)半年度净利润5.85亿元 同比增长3.65%",
    "href": "http://stock.jrj.com.cn/2022/08/30034536950092.shtml",
    "datetime": "2022-08-30 03:45:13",
    "code": "300759"
  },
  {
    "title": "再遭套现50亿，“中信系”和君联资本轮番减持康龙化成",
    "href": "http://stock.jrj.com.cn/2022/08/24205536932107.shtml",
    "datetime": "2022-08-24 20:55:20",
    "code": "300759"
  },
  {
    "title": "康龙化成：两名股东拟合计减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2022/08/23163036926370.shtml",
    "datetime": "2022-08-23 16:30:58",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：信中康成、信中龙成拟合计减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2022/08/23162636926359.shtml",
    "datetime": "2022-08-23 16:26:50",
    "code": "300759"
  },
  {
    "title": "券业场|东方证券原保代李正已离职 曾保荐康龙化成、金盾股份等多个IPO项目",
    "href": "http://stock.jrj.com.cn/2022/08/22173936921988.shtml",
    "datetime": "2022-08-22 17:39:56",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人之一的楼小强及其一致行动人合计质押295万股",
    "href": "http://stock.jrj.com.cn/2022/08/16160336904434.shtml",
    "datetime": "2022-08-16 16:03:17",
    "code": "300759"
  },
  {
    "title": "康龙化成减持受关注 实控人持续看好公司发展前景",
    "href": "http://stock.jrj.com.cn/2022/08/09143036882463.shtml",
    "datetime": "2022-08-09 14:30:06",
    "code": "300759"
  },
  {
    "title": "康龙化成24亿商誉悬顶净利原地踏步 市值一年蒸发千亿实控人拟再套现22亿",
    "href": "http://stock.jrj.com.cn/2022/08/09113236882082.shtml",
    "datetime": "2022-08-09 11:32:30",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持5.88万股",
    "href": "http://stock.jrj.com.cn/2022/08/09070236881239.shtml",
    "datetime": "2022-08-09 07:02:30",
    "code": "300759"
  },
  {
    "title": "A股异动 | 康龙化成(300759.SZ)跌4.8% 实控人拟减持不超2.33%股份",
    "href": "http://stock.jrj.com.cn/2022/08/08101636877913.shtml",
    "datetime": "2022-08-08 10:16:12",
    "code": "300759"
  },
  {
    "title": "康龙化成：实控人及一致行动人拟减持不超2.33%股份",
    "href": "http://stock.jrj.com.cn/2022/08/05171636874150.shtml",
    "datetime": "2022-08-05 17:16:17",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人方面拟减持不超2.33%股份",
    "href": "http://stock.jrj.com.cn/2022/08/05171036874168.shtml",
    "datetime": "2022-08-05 17:10:03",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：向379名激励对象授予220.32万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/07/28212336851925.shtml",
    "datetime": "2022-07-28 21:23:26",
    "code": "300759"
  },
  {
    "title": "单日A股市值蒸发百亿？高频收购布局新业务，康龙化成利润问题待解？",
    "href": "http://stock.jrj.com.cn/2022/07/27170236847257.shtml",
    "datetime": "2022-07-27 17:02:25",
    "code": "300759"
  },
  {
    "title": "康龙化成：受欧美通胀影响 预计利润端增速可能会慢几个点",
    "href": "http://stock.jrj.com.cn/2022/07/19175436825661.shtml",
    "datetime": "2022-07-19 17:54:17",
    "code": "300759"
  },
  {
    "title": "康龙化成预计2022年中期归母净利5.65亿至6.10亿元",
    "href": "http://stock.jrj.com.cn/2022/07/18172936821758.shtml",
    "datetime": "2022-07-18 17:29:58",
    "code": "300759"
  },
  {
    "title": "港A两地CRO板块集体下挫 康龙化成上半年增收不增利",
    "href": "http://stock.jrj.com.cn/2022/07/18094636819991.shtml",
    "datetime": "2022-07-18 09:46:14",
    "code": "300759"
  },
  {
    "title": "康龙化成AH股齐挫 预计上半年净利同比增幅仅0%-8%",
    "href": "http://stock.jrj.com.cn/2022/07/18093736819935.shtml",
    "datetime": "2022-07-18 09:37:16",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)：预计上半年净利润5.65亿元-6.1亿元",
    "href": "http://stock.jrj.com.cn/2022/07/17193536818648.shtml",
    "datetime": "2022-07-17 19:35:33",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)半年度经调整净利润预增19%-27%",
    "href": "http://stock.jrj.com.cn/2022/07/17163536818475.shtml",
    "datetime": "2022-07-17 16:35:12",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强质押155万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2022/07/15201036817135.shtml",
    "datetime": "2022-07-15 20:10:50",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人之一楼小强质押155万股",
    "href": "http://stock.jrj.com.cn/2022/07/15155336815947.shtml",
    "datetime": "2022-07-15 15:53:35",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)按“10转增5”基准发行资本化股份",
    "href": "http://stock.jrj.com.cn/2022/07/05175136784141.shtml",
    "datetime": "2022-07-05 17:51:47",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强质押46万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2022/06/14215236729232.shtml",
    "datetime": "2022-06-14 21:52:21",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人楼小强质押46万股",
    "href": "http://stock.jrj.com.cn/2022/06/14155936727665.shtml",
    "datetime": "2022-06-14 15:59:19",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)2021年度权益分派10转5派4.5元 股权登记日为6月13日",
    "href": "http://stock.jrj.com.cn/2022/06/07200636710281.shtml",
    "datetime": "2022-06-07 20:06:41",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭贝莱德减持7.37万股",
    "href": "http://stock.jrj.com.cn/2022/06/01070436695250.shtml",
    "datetime": "2022-06-01 07:04:18",
    "code": "300759"
  },
  {
    "title": "康龙化成2名股东合计减持828.07万股 套现合计约9.27亿 2021年公司净利16.61亿",
    "href": "http://stock.jrj.com.cn/2022/05/27221136686324.shtml",
    "datetime": "2022-05-27 22:11:16",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：信中康成及其一致行动人自4月1日起累计减持1.04%股份",
    "href": "http://stock.jrj.com.cn/2022/05/27184036685586.shtml",
    "datetime": "2022-05-27 18:40:55",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)回购及注销13.2万股限制性A股股票",
    "href": "http://stock.jrj.com.cn/2022/05/25165036677867.shtml",
    "datetime": "2022-05-25 16:50:23",
    "code": "300759"
  },
  {
    "title": "康龙化成AH股齐跌 大股东近数月共减持逾1640万股A股",
    "href": "http://stock.jrj.com.cn/2022/05/24093736672778.shtml",
    "datetime": "2022-05-24 09:37:05",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：减持期过半 信中康成、信中龙成已合计减持2.07%股份",
    "href": "http://stock.jrj.com.cn/2022/05/23181436671112.shtml",
    "datetime": "2022-05-23 18:14:53",
    "code": "300759"
  },
  {
    "title": "港股异动 | 康龙化成跌4% 被贝莱德减持8.3097万股",
    "href": "http://stock.jrj.com.cn/2022/05/18103136657761.shtml",
    "datetime": "2022-05-18 10:31:34",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭贝莱德减持6.52万股",
    "href": "http://stock.jrj.com.cn/2022/05/16064336649539.shtml",
    "datetime": "2022-05-16 06:43:44",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强质押60万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2022/05/13185236647462.shtml",
    "datetime": "2022-05-13 18:52:01",
    "code": "300759"
  },
  {
    "title": "康龙化成：实控人之一楼小强所持60万股质押 占公司总股本比例0.08%",
    "href": "http://stock.jrj.com.cn/2022/05/13130236646028.shtml",
    "datetime": "2022-05-13 13:02:04",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人之一楼小强质押60万股",
    "href": "http://stock.jrj.com.cn/2022/05/13115136645827.shtml",
    "datetime": "2022-05-13 11:51:51",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：111.2834万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2022/05/10210336624496.shtml",
    "datetime": "2022-05-10 21:03:15",
    "code": "300759"
  },
  {
    "title": "康龙化成完成收购安凯毅博100%股权",
    "href": "http://stock.jrj.com.cn/2022/05/09141136605394.shtml",
    "datetime": "2022-05-09 14:11:37",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭The Capital Group减持46.84万股",
    "href": "http://stock.jrj.com.cn/2022/05/04064936552299.shtml",
    "datetime": "2022-05-04 06:49:49",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)：一季度净利2.49亿元 同比增长1.31%",
    "href": "http://stock.jrj.com.cn/2022/04/28181336494110.shtml",
    "datetime": "2022-04-28 18:13:07",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：信中康成方面减持比例达1.12%",
    "href": "http://stock.jrj.com.cn/2022/04/01161236247412.shtml",
    "datetime": "2022-04-01 16:12:59",
    "code": "300759"
  },
  {
    "title": "康龙化成2名实际控制人合计质押38万股 用于股权类投资、补充个人企业流动资金",
    "href": "http://stock.jrj.com.cn/2022/03/31213136242016.shtml",
    "datetime": "2022-03-31 21:31:55",
    "code": "300759"
  },
  {
    "title": "美银证券：升康龙化成(3759.HK)评级至“买入”，目标价上调至116.1港元",
    "href": "http://stock.jrj.com.cn/2022/03/29111736090787.shtml",
    "datetime": "2022-03-29 11:17:31",
    "code": "300759"
  },
  {
    "title": "康龙化成2021年净利16.61亿同比增长41.68% 董事长BoliangLou薪酬819.14万",
    "href": "http://stock.jrj.com.cn/2022/03/28125335841618.shtml",
    "datetime": "2022-03-28 12:53:06",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)拟推154.88万股的2022年A股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/03/27221835652683.shtml",
    "datetime": "2022-03-27 22:18:13",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟对符合资格的员工提供最长5年免息购房借款资助 个人额度不超60万元",
    "href": "http://stock.jrj.com.cn/2022/03/27221635652684.shtml",
    "datetime": "2022-03-27 22:16:02",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟以8360万元收购安凯毅博100%股权",
    "href": "http://stock.jrj.com.cn/2022/03/27221335652685.shtml",
    "datetime": "2022-03-27 22:13:26",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟使用不超40亿元闲置自有资金适时购买中低风险理财产品",
    "href": "http://stock.jrj.com.cn/2022/03/27221135652686.shtml",
    "datetime": "2022-03-27 22:11:08",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)2021年度净利升41.68%至16.61亿元 拟10转5派4.5元",
    "href": "http://stock.jrj.com.cn/2022/03/27155235572637.shtml",
    "datetime": "2022-03-27 15:52:57",
    "code": "300759"
  },
  {
    "title": "康龙化成2021年净利16.61亿同比增长41.68% 各服务模块均实现快速增长",
    "href": "http://stock.jrj.com.cn/2022/03/10225334811422.shtml",
    "datetime": "2022-03-10 22:53:59",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)业绩快报：2021年度净利润升41.68%至16.61亿元",
    "href": "http://stock.jrj.com.cn/2022/03/10190334810425.shtml",
    "datetime": "2022-03-10 19:03:09",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人之一致行动人宁波龙泰康质押78.1万股 用于补充企业流动资金、股权类投资",
    "href": "http://stock.jrj.com.cn/2022/02/22215134436190.shtml",
    "datetime": "2022-02-22 21:51:06",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：宁波龙泰康质押78.1万股",
    "href": "http://stock.jrj.com.cn/2022/02/22193334435674.shtml",
    "datetime": "2022-02-22 19:33:17",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭The Capital Group减持264.08万股",
    "href": "http://stock.jrj.com.cn/2022/02/22064434430590.shtml",
    "datetime": "2022-02-22 06:44:41",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭The Capital Group减持48.69万股",
    "href": "http://stock.jrj.com.cn/2022/02/17070334378141.shtml",
    "datetime": "2022-02-17 07:03:25",
    "code": "300759"
  },
  {
    "title": "康龙化成净利7年高增股价累涨30倍 四大股东接力减持或套现超182亿",
    "href": "http://stock.jrj.com.cn/2022/02/08073234304267.shtml",
    "datetime": "2022-02-08 07:32:58",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：信中康成及信中龙成拟合计减持不超6%的股份",
    "href": "http://stock.jrj.com.cn/2022/01/26152234223072.shtml",
    "datetime": "2022-01-26 15:22:11",
    "code": "300759"
  },
  {
    "title": "A股异动 | 康龙化成跌6% 两股东拟合计减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2022/01/26100334221937.shtml",
    "datetime": "2022-01-26 10:03:11",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达和君联茂林已合计减持877.1036万股",
    "href": "http://stock.jrj.com.cn/2022/01/25205834214042.shtml",
    "datetime": "2022-01-25 20:58:06",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：3.73亿股限售股份将于1月28日上市流通",
    "href": "http://stock.jrj.com.cn/2022/01/24213634206628.shtml",
    "datetime": "2022-01-24 21:36:26",
    "code": "300759"
  },
  {
    "title": "60万股民要慌？大批解禁股来了：千亿CXO康龙化成464亿解禁，股价已接近腰斩",
    "href": "http://stock.jrj.com.cn/2022/01/24083534199570.shtml",
    "datetime": "2022-01-24 08:35:14",
    "code": "300759"
  },
  {
    "title": "康龙化成：成熟服务线规模效益逐渐提升 2021年净利同比预增35%-45%",
    "href": "http://stock.jrj.com.cn/2022/01/21194434183998.shtml",
    "datetime": "2022-01-21 19:44:17",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)2021年度净利润预增35%-45%",
    "href": "http://stock.jrj.com.cn/2022/01/21192634183865.shtml",
    "datetime": "2022-01-21 19:26:43",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭The Capital Group减持24万股",
    "href": "http://stock.jrj.com.cn/2022/01/20072534176524.shtml",
    "datetime": "2022-01-20 07:25:10",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强及其一致行动人合计质押125.8万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2022/01/13184734155093.shtml",
    "datetime": "2022-01-13 18:47:07",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：楼小强及其一致行动人质押合计125.8万股",
    "href": "http://stock.jrj.com.cn/2022/01/13174234154667.shtml",
    "datetime": "2022-01-13 17:42:03",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)实控人及其一致行动人质押125.8万股",
    "href": "http://stock.jrj.com.cn/2022/01/13170434154494.shtml",
    "datetime": "2022-01-13 17:04:57",
    "code": "300759"
  },
  {
    "title": "A股1月解禁市值超4300亿元 康龙化成规模居首",
    "href": "http://stock.jrj.com.cn/2022/01/07082534132015.shtml",
    "datetime": "2022-01-07 08:25:20",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获贝莱德增持8.97万股",
    "href": "http://stock.jrj.com.cn/2021/12/29080634079525.shtml",
    "datetime": "2021-12-29 08:06:56",
    "code": "300759"
  },
  {
    "title": "康龙化成：股东君联闻达、君联茂林合计减持800.32万股 占公司总股本比例1.01%",
    "href": "http://stock.jrj.com.cn/2021/12/23182034053714.shtml",
    "datetime": "2021-12-23 18:20:41",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达和君联茂林7月15日以来共减持1.01%股份",
    "href": "http://stock.jrj.com.cn/2021/12/23180234053464.shtml",
    "datetime": "2021-12-23 18:02:54",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持91.38万股",
    "href": "http://stock.jrj.com.cn/2021/12/23074634050605.shtml",
    "datetime": "2021-12-23 07:46:14",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人及其一致行动人质押306万股",
    "href": "http://stock.jrj.com.cn/2021/12/16173934024902.shtml",
    "datetime": "2021-12-16 17:39:48",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭FMR LLC减持50.16万股",
    "href": "http://stock.jrj.com.cn/2021/12/14074834012559.shtml",
    "datetime": "2021-12-14 07:48:19",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达及其一致行动人已累计减持3991.87万股 持股降至6.19%",
    "href": "http://stock.jrj.com.cn/2021/12/10214233996259.shtml",
    "datetime": "2021-12-10 21:42:55",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强质押16万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2021/12/08213233986335.shtml",
    "datetime": "2021-12-08 21:32:03",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人楼小强质押16万股",
    "href": "http://stock.jrj.com.cn/2021/12/08211533986310.shtml",
    "datetime": "2021-12-08 21:15:48",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭贝莱德减持38.81万股",
    "href": "http://stock.jrj.com.cn/2021/12/08074833983400.shtml",
    "datetime": "2021-12-08 07:48:21",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)实控人及其一致行动人质押64万股",
    "href": "http://stock.jrj.com.cn/2021/11/09164233827918.shtml",
    "datetime": "2021-11-09 16:42:33",
    "code": "300759"
  },
  {
    "title": "康龙化成2021财年前三财季净利10.40亿元，同比增长31.81%",
    "href": "http://stock.jrj.com.cn/2021/10/28173133770163.shtml",
    "datetime": "2021-10-28 17:31:09",
    "code": "300759"
  },
  {
    "title": "康龙化成AH齐涨 第三季净利同比增53% 葛兰旗下基金加仓",
    "href": "http://stock.jrj.com.cn/2021/10/28093433767135.shtml",
    "datetime": "2021-10-28 09:34:26",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：第三季度净利升53.26%至4.75亿元",
    "href": "http://stock.jrj.com.cn/2021/10/27191433763443.shtml",
    "datetime": "2021-10-27 19:14:34",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)完成回购及注销部分限制性A股股票",
    "href": "http://stock.jrj.com.cn/2021/10/27182933763093.shtml",
    "datetime": "2021-10-27 18:29:38",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)：前三季净利10.4亿元 同比增长31.81%",
    "href": "http://stock.jrj.com.cn/2021/10/27182533763077.shtml",
    "datetime": "2021-10-27 18:25:36",
    "code": "300759"
  },
  {
    "title": "康龙化成：前三季度净利同比增长31.81%",
    "href": "http://stock.jrj.com.cn/2021/10/27175433762692.shtml",
    "datetime": "2021-10-27 17:54:56",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)10月27日举行董事会会议审批三季度业绩",
    "href": "http://stock.jrj.com.cn/2021/10/15164933698936.shtml",
    "datetime": "2021-10-15 16:49:13",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持52.35万股",
    "href": "http://stock.jrj.com.cn/2021/09/29082633534652.shtml",
    "datetime": "2021-09-29 08:26:56",
    "code": "300759"
  },
  {
    "title": "康龙化成2名股东拟合计减持不超2383.16万股公司股份 上半年公司净利5.65亿",
    "href": "http://stock.jrj.com.cn/2021/09/24205233511681.shtml",
    "datetime": "2021-09-24 20:52:12",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达方面拟合计减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2021/09/24165033510476.shtml",
    "datetime": "2021-09-24 16:50:10",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达和君联茂林已合计减持1998.64万股",
    "href": "http://stock.jrj.com.cn/2021/09/23220533506858.shtml",
    "datetime": "2021-09-23 22:05:59",
    "code": "300759"
  },
  {
    "title": "康龙化成2名股东合计减持1998.64万股 套现合计36.59亿 上半年公司净利5.65亿",
    "href": "http://stock.jrj.com.cn/2021/09/23213333506669.shtml",
    "datetime": "2021-09-23 21:33:02",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持16.806万股",
    "href": "http://stock.jrj.com.cn/2021/09/23083433502788.shtml",
    "datetime": "2021-09-23 08:34:23",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持23.6万股",
    "href": "http://stock.jrj.com.cn/2021/09/21074133480622.shtml",
    "datetime": "2021-09-21 07:41:00",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人的一致行动人质押8.5万股 用于投资私募股权基金",
    "href": "http://stock.jrj.com.cn/2021/09/17184833452768.shtml",
    "datetime": "2021-09-17 18:48:54",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)实控人一致行动人质押8.5万股",
    "href": "http://stock.jrj.com.cn/2021/09/17175133452422.shtml",
    "datetime": "2021-09-17 17:51:38",
    "code": "300759"
  },
  {
    "title": "CXO景气度提升，康龙化成涨超3%，恒生医疗ETF（513060）高开高走",
    "href": "http://stock.jrj.com.cn/2021/09/14103133432727.shtml",
    "datetime": "2021-09-14 10:31:01",
    "code": "300759"
  },
  {
    "title": "康龙化成2021年半年度净利5.65亿元 同比净利增加17.93%",
    "href": "http://stock.jrj.com.cn/2021/08/29194233341315.shtml",
    "datetime": "2021-08-29 19:42:21",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：上半年净利增17.93%至5.65亿元",
    "href": "http://stock.jrj.com.cn/2021/08/29172733340783.shtml",
    "datetime": "2021-08-29 17:27:11",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭贝莱德减持73.63万股",
    "href": "http://stock.jrj.com.cn/2021/08/23065833300135.shtml",
    "datetime": "2021-08-23 06:58:42",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获美国资本集团增持72.77万股",
    "href": "http://stock.jrj.com.cn/2021/08/18063633270175.shtml",
    "datetime": "2021-08-18 06:36:24",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强质押30万股 用于股权投资类",
    "href": "http://stock.jrj.com.cn/2021/08/13200533250396.shtml",
    "datetime": "2021-08-13 20:05:09",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人之一楼小强质押30万股",
    "href": "http://stock.jrj.com.cn/2021/08/13162333249000.shtml",
    "datetime": "2021-08-13 16:23:15",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持22.6万股",
    "href": "http://stock.jrj.com.cn/2021/08/11065633235031.shtml",
    "datetime": "2021-08-11 06:56:33",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭贝莱德减持18.89万股",
    "href": "http://stock.jrj.com.cn/2021/08/11065333235030.shtml",
    "datetime": "2021-08-11 06:53:36",
    "code": "300759"
  },
  {
    "title": "三大指数午后全线翻红，CXO发力康龙化成大涨7%再创历史新高",
    "href": "http://stock.jrj.com.cn/2021/08/05132533206355.shtml",
    "datetime": "2021-08-05 13:25:02",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟出资6800万元参与私募股权投资基金君联惠康",
    "href": "http://stock.jrj.com.cn/2021/07/27212533159860.shtml",
    "datetime": "2021-07-27 21:25:47",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：向204名激励对象授予77.42万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/07/27193333159377.shtml",
    "datetime": "2021-07-27 19:33:52",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持23.34万股",
    "href": "http://stock.jrj.com.cn/2021/07/26070633150275.shtml",
    "datetime": "2021-07-26 07:06:39",
    "code": "300759"
  },
  {
    "title": "CRO龙头康龙化成暴跌15%，砸出新的“黄金坑”！",
    "href": "http://stock.jrj.com.cn/2021/07/16175433108383.shtml",
    "datetime": "2021-07-16 17:54:44",
    "code": "300759"
  },
  {
    "title": "CXO龙头康龙化成跌近12%，双创指数跌幅扩大",
    "href": "http://stock.jrj.com.cn/2021/07/16133833107009.shtml",
    "datetime": "2021-07-16 13:38:51",
    "code": "300759"
  },
  {
    "title": "康龙化成AH股齐跌 上半年净利预增4%-24%",
    "href": "http://stock.jrj.com.cn/2021/07/16094433105858.shtml",
    "datetime": "2021-07-16 09:44:56",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)上半年扣非净利预增46%-66%",
    "href": "http://stock.jrj.com.cn/2021/07/16061433104365.shtml",
    "datetime": "2021-07-16 06:14:18",
    "code": "300759"
  },
  {
    "title": "康龙化成2021年上半年预计净利4.98亿-5.94亿增长4%-24% 运营效率逐渐提升",
    "href": "http://stock.jrj.com.cn/2021/07/15215333104124.shtml",
    "datetime": "2021-07-15 21:53:06",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达和君联茂林已减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/15213533103722.shtml",
    "datetime": "2021-07-15 21:35:53",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)半年度扣非净利润预增46%-66%",
    "href": "http://stock.jrj.com.cn/2021/07/15205733103566.shtml",
    "datetime": "2021-07-15 20:57:21",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭FMR LLC减持62.38万股",
    "href": "http://stock.jrj.com.cn/2021/07/13074633086369.shtml",
    "datetime": "2021-07-13 07:46:13",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强质押10万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2021/06/30201433023368.shtml",
    "datetime": "2021-06-30 20:14:38",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)实控人质押10万股A股",
    "href": "http://stock.jrj.com.cn/2021/06/30163333021916.shtml",
    "datetime": "2021-06-30 16:33:51",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人之一楼小强质押10万股",
    "href": "http://stock.jrj.com.cn/2021/06/30154833021677.shtml",
    "datetime": "2021-06-30 15:48:58",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)A股拟10派3元 股权登记日6月29日",
    "href": "http://stock.jrj.com.cn/2021/06/24175732990542.shtml",
    "datetime": "2021-06-24 17:57:18",
    "code": "300759"
  },
  {
    "title": "康龙化成2名股东合计减持1676.85万股 套现合计29.62亿",
    "href": "http://stock.jrj.com.cn/2021/06/23201232984825.shtml",
    "datetime": "2021-06-23 20:12:30",
    "code": "300759"
  },
  {
    "title": "康龙化成：公司目前经营正常",
    "href": "http://stock.jrj.com.cn/2021/06/23171232983628.shtml",
    "datetime": "2021-06-23 17:12:49",
    "code": "300759"
  },
  {
    "title": "康龙化成：公司正在通过海外并购和合作 掌握细胞和基因疗法的先进技术 以逐步完善细胞和基因疗法服务平台",
    "href": "http://stock.jrj.com.cn/2021/06/23171232983626.shtml",
    "datetime": "2021-06-23 17:12:39",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：减持期过半 君联闻达及君联茂林合计减持2.11%股份",
    "href": "http://stock.jrj.com.cn/2021/06/23161532983222.shtml",
    "datetime": "2021-06-23 16:15:21",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)2020年度权益分派10派3元 股权登记日为6月29日",
    "href": "http://stock.jrj.com.cn/2021/06/22172232976900.shtml",
    "datetime": "2021-06-22 17:22:31",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：完成发行3亿美元可转债及人民币19.16亿元的美元结算可转债",
    "href": "http://stock.jrj.com.cn/2021/06/18194832956320.shtml",
    "datetime": "2021-06-18 19:48:06",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)完成发行3亿美元及19.16亿元债券",
    "href": "http://stock.jrj.com.cn/2021/06/18185232955980.shtml",
    "datetime": "2021-06-18 18:52:24",
    "code": "300759"
  },
  {
    "title": "A股异动丨康龙化成(300759.SZ)再创历史新高 拟授予激励对象77.42万股限制性A股",
    "href": "http://stock.jrj.com.cn/2021/06/10104532904113.shtml",
    "datetime": "2021-06-10 10:45:05",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)建议削减注册资",
    "href": "http://stock.jrj.com.cn/2021/06/09223332901880.shtml",
    "datetime": "2021-06-09 22:33:52",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟授予激励对象77.42万股限制性A股",
    "href": "http://stock.jrj.com.cn/2021/06/09205932901343.shtml",
    "datetime": "2021-06-09 20:59:27",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟发行可转换为H股的美元可转债和人民币计值美元结算可转债",
    "href": "http://stock.jrj.com.cn/2021/06/08163732893751.shtml",
    "datetime": "2021-06-08 16:37:36",
    "code": "300759"
  },
  {
    "title": "康龙化成：公司具有分子砌块领域这方面的服务能力",
    "href": "http://stock.jrj.com.cn/2021/06/04211032876450.shtml",
    "datetime": "2021-06-04 21:10:43",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达和君联茂林已减持808万股",
    "href": "http://stock.jrj.com.cn/2021/05/26201632824986.shtml",
    "datetime": "2021-05-26 20:16:29",
    "code": "300759"
  },
  {
    "title": "康龙化成：近日股东君联闻达和君联茂林减持公司总股本1.02%",
    "href": "http://stock.jrj.com.cn/2021/05/26200932824957.shtml",
    "datetime": "2021-05-26 20:09:33",
    "code": "300759"
  },
  {
    "title": "康龙化成AH股齐升 A股升超4%创历史新高",
    "href": "http://stock.jrj.com.cn/2021/05/17133332768800.shtml",
    "datetime": "2021-05-17 13:33:05",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持7.72万股",
    "href": "http://stock.jrj.com.cn/2021/05/14071432752554.shtml",
    "datetime": "2021-05-14 07:14:52",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)拉升涨近5%创上市新高 获纳入MSCI中国A股指数",
    "href": "http://stock.jrj.com.cn/2021/05/12144032741804.shtml",
    "datetime": "2021-05-12 14:40:36",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持7.46万股",
    "href": "http://stock.jrj.com.cn/2021/05/12071732739659.shtml",
    "datetime": "2021-05-12 07:17:08",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持13.64万股",
    "href": "http://stock.jrj.com.cn/2021/05/11082132733751.shtml",
    "datetime": "2021-05-11 08:21:28",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)：持股5%以上股东及其一致行动人股份减持比例达到1%",
    "href": "http://stock.jrj.com.cn/2021/05/07164232708369.shtml",
    "datetime": "2021-05-07 16:42:25",
    "code": "300759"
  },
  {
    "title": "康龙化成：持股5%以上股东及其一致行动人已减持1.01%公司股份",
    "href": "http://stock.jrj.com.cn/2021/05/07161132708445.shtml",
    "datetime": "2021-05-07 16:11:46",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达和君联茂林已减持1.01%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/07154632708048.shtml",
    "datetime": "2021-05-07 15:46:30",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持25.53万股",
    "href": "http://stock.jrj.com.cn/2021/05/07072332705612.shtml",
    "datetime": "2021-05-07 07:23:03",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持29.15万股",
    "href": "http://stock.jrj.com.cn/2021/04/30070232484080.shtml",
    "datetime": "2021-04-30 07:02:57",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭FMR LLC减持10.01万股",
    "href": "http://stock.jrj.com.cn/2021/04/20084232407396.shtml",
    "datetime": "2021-04-20 08:42:01",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)4月28日举行董事会议审批一季度业绩",
    "href": "http://stock.jrj.com.cn/2021/04/14175532372699.shtml",
    "datetime": "2021-04-14 17:55:34",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获FMR LLC增持28.72万股",
    "href": "http://stock.jrj.com.cn/2021/04/14073332368859.shtml",
    "datetime": "2021-04-14 07:33:41",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持10.31万股",
    "href": "http://stock.jrj.com.cn/2021/04/08073132329431.shtml",
    "datetime": "2021-04-08 07:31:19",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根士丹利增持40.95万股",
    "href": "http://stock.jrj.com.cn/2021/03/30100732246488.shtml",
    "datetime": "2021-03-30 10:07:54",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟以2.6亿元参与关联方康君投资和宁波康湾设立的康君仲元",
    "href": "http://stock.jrj.com.cn/2021/03/28210332231302.shtml",
    "datetime": "2021-03-28 21:03:34",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟使用合计不超40亿元闲置自有资金适时购买中低风险理财产品",
    "href": "http://stock.jrj.com.cn/2021/03/28205932231276.shtml",
    "datetime": "2021-03-28 20:59:42",
    "code": "300759"
  },
  {
    "title": "康龙化成2020年净利增长114.25% 董事长Boliang Lou薪酬417万",
    "href": "http://stock.jrj.com.cn/2021/03/28195332231070.shtml",
    "datetime": "2021-03-28 19:53:52",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)2020年归母净利增长114.25%至11.72亿元 拟10派3元",
    "href": "http://stock.jrj.com.cn/2021/03/28162532230046.shtml",
    "datetime": "2021-03-28 16:25:49",
    "code": "300759"
  },
  {
    "title": "康龙化成年度报告：2020年净利润同比增长114% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2021/03/28161232230020.shtml",
    "datetime": "2021-03-28 16:12:59",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获FMR LLC增持27.44万股",
    "href": "http://stock.jrj.com.cn/2021/03/26085432220939.shtml",
    "datetime": "2021-03-26 08:54:01",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获FMR LLC增持26.41万股",
    "href": "http://stock.jrj.com.cn/2021/03/19083032161499.shtml",
    "datetime": "2021-03-19 08:30:03",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)3月26日举行董事会会议审批年度业绩",
    "href": "http://stock.jrj.com.cn/2021/03/12164132115698.shtml",
    "datetime": "2021-03-12 16:41:19",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人的一致行动人龙泰康质押126.5万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2021/03/11204432110947.shtml",
    "datetime": "2021-03-11 20:44:23",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人的一致行动人龙泰康质押126.5万股",
    "href": "http://stock.jrj.com.cn/2021/03/11160332109565.shtml",
    "datetime": "2021-03-11 16:03:00",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭FMR LLC减持22.5万股",
    "href": "http://stock.jrj.com.cn/2021/03/08072332088934.shtml",
    "datetime": "2021-03-08 07:23:41",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获贝莱德增持27.8万股",
    "href": "http://stock.jrj.com.cn/2021/03/04072032068432.shtml",
    "datetime": "2021-03-04 07:20:10",
    "code": "300759"
  },
  {
    "title": "康龙化成2名股东合计减持3171.56万股 套现合计约33.12亿",
    "href": "http://stock.jrj.com.cn/2021/03/01214832052784.shtml",
    "datetime": "2021-03-01 21:48:11",
    "code": "300759"
  },
  {
    "title": "康龙化成：君联闻达及其一致行动人君联茂林拟合计减持不超5%公司股份",
    "href": "http://stock.jrj.com.cn/2021/03/01183232051580.shtml",
    "datetime": "2021-03-01 18:32:04",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达及其一致行动人拟合计减持不超5%股份",
    "href": "http://stock.jrj.com.cn/2021/03/01182932051567.shtml",
    "datetime": "2021-03-01 18:29:33",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：两股东减持期届满 合计减持3171.56万股",
    "href": "http://stock.jrj.com.cn/2021/03/01182732051557.shtml",
    "datetime": "2021-03-01 18:27:26",
    "code": "300759"
  },
  {
    "title": "港股异动 | 康龙化成(3759.HK)涨超6% 拟1.2亿美元收购生物制剂服务企业",
    "href": "http://stock.jrj.com.cn/2021/03/01153232050252.shtml",
    "datetime": "2021-03-01 15:32:22",
    "code": "300759"
  },
  {
    "title": "康龙化成附属拟1.2亿美元收购生物制剂公司ABL全部股权",
    "href": "http://stock.jrj.com.cn/2021/03/01114532049071.shtml",
    "datetime": "2021-03-01 11:45:30",
    "code": "300759"
  },
  {
    "title": "康龙化成拟1.2亿美元收购境外公司100%股权：加强全球化布局",
    "href": "http://stock.jrj.com.cn/2021/03/01094632048242.shtml",
    "datetime": "2021-03-01 09:46:25",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：拟斥1.2亿美元收购生物制剂公司Allergan Biologics",
    "href": "http://stock.jrj.com.cn/2021/03/01083532047796.shtml",
    "datetime": "2021-03-01 08:35:08",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)拟1.2亿美元收购境外公司100%股权",
    "href": "http://stock.jrj.com.cn/2021/03/01074132047607.shtml",
    "datetime": "2021-03-01 07:41:22",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持16.92万股",
    "href": "http://stock.jrj.com.cn/2021/02/24073932016216.shtml",
    "datetime": "2021-02-24 07:39:24",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持28.4万股",
    "href": "http://stock.jrj.com.cn/2021/02/22065632003030.shtml",
    "datetime": "2021-02-22 06:56:51",
    "code": "300759"
  },
  {
    "title": "康龙化成：持续打造并不断完善深度融合的全流程一体化和国际化的药物研发服务平台始终是公司的核心发展战略",
    "href": "http://stock.jrj.com.cn/2021/02/19161031992900.shtml",
    "datetime": "2021-02-19 16:10:24",
    "code": "300759"
  },
  {
    "title": "康龙化成股东北京多泰质押85万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2021/02/05203731856246.shtml",
    "datetime": "2021-02-05 20:37:17",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：北京多泰质押85万股",
    "href": "http://stock.jrj.com.cn/2021/02/05155431854748.shtml",
    "datetime": "2021-02-05 15:54:09",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持21.4万股",
    "href": "http://stock.jrj.com.cn/2021/02/05080131852751.shtml",
    "datetime": "2021-02-05 08:01:19",
    "code": "300759"
  },
  {
    "title": "康龙化成今股价跌8% 中泰证券浙商证券昨日刚喊买入",
    "href": "http://stock.jrj.com.cn/2021/01/26180731778761.shtml",
    "datetime": "2021-01-26 18:07:00",
    "code": "300759"
  },
  {
    "title": "康龙化成2020年预计净利11.33亿-11.87亿增长107%-117% 运营效率逐渐提升",
    "href": "http://stock.jrj.com.cn/2021/01/25212531768857.shtml",
    "datetime": "2021-01-25 21:25:32",
    "code": "300759"
  },
  {
    "title": "CRO概念股集体走强 泰格医药、药明康德、康龙化成、药石科技均创历史新高",
    "href": "http://stock.jrj.com.cn/2021/01/22153331744884.shtml",
    "datetime": "2021-01-22 15:33:14",
    "code": "300759"
  },
  {
    "title": "康龙化成飙涨11%，泰格医药、药明康德涨超7%！CRO行业究竟发生了什么？",
    "href": "http://stock.jrj.com.cn/2021/01/20113631727647.shtml",
    "datetime": "2021-01-20 11:36:07",
    "code": "300759"
  },
  {
    "title": "康龙化成：公司进一步引进专业技术人才建设扩大业务团队",
    "href": "http://stock.jrj.com.cn/2021/01/08164531655909.shtml",
    "datetime": "2021-01-08 16:45:20",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)：实控人的一致行动人龙泰康质押70万股A股",
    "href": "http://stock.jrj.com.cn/2020/12/28171031586843.shtml",
    "datetime": "2020-12-28 17:10:09",
    "code": "300759"
  },
  {
    "title": "康龙化成股东龙泰康质押70万股用于股权类投资",
    "href": "http://stock.jrj.com.cn/2020/12/25193231571887.shtml",
    "datetime": "2020-12-25 19:32:41",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人的一致行动人龙泰康质押70万股",
    "href": "http://stock.jrj.com.cn/2020/12/25161631570540.shtml",
    "datetime": "2020-12-25 16:16:50",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：君联闻达和君联茂林已减持803.59万股",
    "href": "http://stock.jrj.com.cn/2020/12/21155231536424.shtml",
    "datetime": "2020-12-21 15:52:03",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获FMR LLC增持13.38万股",
    "href": "http://stock.jrj.com.cn/2020/12/18083531515519.shtml",
    "datetime": "2020-12-18 08:35:50",
    "code": "300759"
  },
  {
    "title": "康龙化成：目前公司天津工厂工程项目推进稳步有序",
    "href": "http://stock.jrj.com.cn/2020/12/17101931507795.shtml",
    "datetime": "2020-12-17 10:19:50",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获FIDELITY INVESTMENT TRUST增持22.77万股",
    "href": "http://stock.jrj.com.cn/2020/12/16090031499373.shtml",
    "datetime": "2020-12-16 09:00:46",
    "code": "300759"
  },
  {
    "title": "康龙化成实际控制人楼小强质押51万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2020/12/08191631442159.shtml",
    "datetime": "2020-12-08 19:16:46",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人楼小强质押51万股",
    "href": "http://stock.jrj.com.cn/2020/12/08154731440060.shtml",
    "datetime": "2020-12-08 15:47:10",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭摩根大通减持81.71万股",
    "href": "http://stock.jrj.com.cn/2020/12/08085031436869.shtml",
    "datetime": "2020-12-08 08:50:23",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获Citigroup Inc.增持77.2万股",
    "href": "http://stock.jrj.com.cn/2020/12/07093931427432.shtml",
    "datetime": "2020-12-07 09:39:45",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获贝莱德增持415.2万股",
    "href": "http://stock.jrj.com.cn/2020/12/07093631427416.shtml",
    "datetime": "2020-12-07 09:36:14",
    "code": "300759"
  },
  {
    "title": "港股异动 | 康龙化成(3759.HK)跌逾5% 较半月前创下的历史新高已回落20%",
    "href": "http://stock.jrj.com.cn/2020/11/24151531338798.shtml",
    "datetime": "2020-11-24 15:15:40",
    "code": "300759"
  },
  {
    "title": "康龙化成跌近10% 浙商证券万联证券高位喊买帮割韭菜？",
    "href": "http://stock.jrj.com.cn/2020/11/18163531308500.shtml",
    "datetime": "2020-11-18 16:35:00",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持20.63万股",
    "href": "http://stock.jrj.com.cn/2020/11/18075931305226.shtml",
    "datetime": "2020-11-18 07:59:33",
    "code": "300759"
  },
  {
    "title": "康龙化成2020年前三季度净利7.89亿增长140.28% 公司整体发展态势良好",
    "href": "http://stock.jrj.com.cn/2020/10/29203631159314.shtml",
    "datetime": "2020-10-29 20:36:41",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭HSBC Global Asset减持2.39万股",
    "href": "http://stock.jrj.com.cn/2020/10/22073131106068.shtml",
    "datetime": "2020-10-22 07:31:53",
    "code": "300759"
  },
  {
    "title": "港股异动 | 康龙化成(3759.HK)续涨逾6% 拟出资1亿元参股医疗投资基金",
    "href": "http://stock.jrj.com.cn/2020/10/21101231098677.shtml",
    "datetime": "2020-10-21 10:12:02",
    "code": "300759"
  },
  {
    "title": "康龙化成拟以自有资金认缴出资1亿元参与投资合伙企业",
    "href": "http://stock.jrj.com.cn/2020/10/19215031086118.shtml",
    "datetime": "2020-10-19 21:50:32",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人一致行动人质押245.2万股",
    "href": "http://stock.jrj.com.cn/2020/10/16125431067192.shtml",
    "datetime": "2020-10-16 12:54:35",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)获摩根大通增持42.72万股",
    "href": "http://stock.jrj.com.cn/2020/10/16084331065589.shtml",
    "datetime": "2020-10-16 08:43:33",
    "code": "300759"
  },
  {
    "title": "康龙化成(03759.HK)遭FMR LLC减持10.35万股",
    "href": "http://stock.jrj.com.cn/2020/10/13074431041034.shtml",
    "datetime": "2020-10-13 07:44:50",
    "code": "300759"
  },
  {
    "title": "康龙化成3名股东合计质押281.8万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2020/09/21190930804012.shtml",
    "datetime": "2020-09-21 19:09:25",
    "code": "300759"
  },
  {
    "title": "康龙化成(300759.SZ)：实控人楼小强及一致行动人质押281.8万股",
    "href": "http://stock.jrj.com.cn/2020/09/21125930801955.shtml",
    "datetime": "2020-09-21 12:59:09",
    "code": "300759"
  },
  {
    "title": "A股异动 | 康龙化成(300759.SZ)跌5.6% 持股5%以上股东已减持794.4万股",
    "href": "http://stock.jrj.com.cn/2020/09/04131730676272.shtml",
    "datetime": "2020-09-04 13:17:22",
    "code": "300759"
  },
  {
    "title": "康龙化成拟投资35亿元建设生物医药基地项目 达安基因上半年归母净利润增长超10倍 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/31185130644859.shtml",
    "datetime": "2020-08-31 18:51:09",
    "code": "300759"
  },
  {
    "title": "康龙化成拟建生物医药基地 未来总投资意向35亿元",
    "href": "http://stock.jrj.com.cn/2020/08/28222830617115.shtml",
    "datetime": "2020-08-28 22:28:21",
    "code": "300759"
  },
  {
    "title": "康龙化成：拟在宁波市杭州湾新区建设生物医药基地项目",
    "href": "http://stock.jrj.com.cn/2020/08/28202230616354.shtml",
    "datetime": "2020-08-28 20:22:00",
    "code": "300759"
  },
  {
    "title": "康龙化成拟在宁波市杭州湾新区建设生物医药基地项目",
    "href": "http://stock.jrj.com.cn/2020/08/28201430616289.shtml",
    "datetime": "2020-08-28 20:14:03",
    "code": "300759"
  },
  {
    "title": "康龙化成上半年净利润同比增长197%",
    "href": "http://stock.jrj.com.cn/2020/08/26192230595826.shtml",
    "datetime": "2020-08-26 19:22:05",
    "code": "300759"
  },
  {
    "title": "康龙化成2020年上半年净利4.79亿增长196.89% 收入规模不断扩大",
    "href": "http://stock.jrj.com.cn/2020/08/26190930595734.shtml",
    "datetime": "2020-08-26 19:09:41",
    "code": "300759"
  },
  {
    "title": "康龙化成董事会、监事会完成换届选举及聘任高级管理人员",
    "href": "http://stock.jrj.com.cn/2020/07/28222630366410.shtml",
    "datetime": "2020-07-28 22:26:56",
    "code": "300759"
  },
  {
    "title": "康龙化成盘中一度涨停 预计上半年净利润同比增长180%到210%",
    "href": "http://stock.jrj.com.cn/2020/07/16102730258843.shtml",
    "datetime": "2020-07-16 10:27:30",
    "code": "300759"
  },
  {
    "title": "康龙化成2020年上半年预计净利4.52亿-5亿 主营业务收入增长",
    "href": "http://stock.jrj.com.cn/2020/07/15214030253316.shtml",
    "datetime": "2020-07-15 21:40:52",
    "code": "300759"
  },
  {
    "title": "康龙化成：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15200030252761.shtml",
    "datetime": "2020-07-15 20:00:00",
    "code": "300759"
  },
  {
    "title": "【龙虎榜】康龙化成7月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/03180130135543.shtml",
    "datetime": "2020-07-03 18:01:51",
    "code": "300759"
  },
  {
    "title": "快讯：康龙化成急速拉升9.99% 主力资金净流入2311.11万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/03134830133176.shtml",
    "datetime": "2020-07-03 13:48:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成宣布控股联斯达",
    "href": "http://stock.jrj.com.cn/2020/07/03000031456702.shtml",
    "datetime": "2020-07-03 00:00:00",
    "code": "300759"
  },
  {
    "title": "康龙化成子公司拟申请银行综合授信 公司将为其提供不超4亿元（含等值外币）担保额度",
    "href": "http://stock.jrj.com.cn/2020/06/24213930012594.shtml",
    "datetime": "2020-06-24 21:39:17",
    "code": "300759"
  },
  {
    "title": "康龙化成股东Wish Bloom拟减持股份 预计减持不超总股本1.88%",
    "href": "http://stock.jrj.com.cn/2020/05/22233029742892.shtml",
    "datetime": "2020-05-22 23:30:35",
    "code": "300759"
  },
  {
    "title": "康龙化成：持股1.88%的股东Wish Bloom Limited拟清仓减持",
    "href": "http://stock.jrj.com.cn/2020/05/22222429742773.shtml",
    "datetime": "2020-05-22 22:24:13",
    "code": "300759"
  },
  {
    "title": "康龙化成3名股东合计减持1795万股 套现约10.08亿元",
    "href": "http://stock.jrj.com.cn/2020/05/20192829723523.shtml",
    "datetime": "2020-05-20 19:28:47",
    "code": "300759"
  },
  {
    "title": "康龙化成第一季度盈利1.02亿同比增长87.16% 收入规模扩大",
    "href": "http://stock.jrj.com.cn/2020/04/29145229418965.shtml",
    "datetime": "2020-04-29 14:52:57",
    "code": "300759"
  },
  {
    "title": "康龙化成：子公司完成增资并取得营业执照",
    "href": "http://stock.jrj.com.cn/2020/04/17222329316124.shtml",
    "datetime": "2020-04-17 22:23:39",
    "code": "300759"
  },
  {
    "title": "多路资金布局医药生物板块 康龙化成等9只潜力股成QFII心头好",
    "href": "http://stock.jrj.com.cn/2020/04/17203029315523.shtml",
    "datetime": "2020-04-17 20:30:03",
    "code": "300759"
  },
  {
    "title": "康龙化成净利五年复合增长率91% 研发人员占比达86%领先同行",
    "href": "http://stock.jrj.com.cn/2020/03/31084029165486.shtml",
    "datetime": "2020-03-31 08:40:35",
    "code": "300759"
  },
  {
    "title": "康龙化成：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/03/29215029136895.shtml",
    "datetime": "2020-03-29 21:50:00",
    "code": "300759"
  },
  {
    "title": "康龙化成2020年一季度预计净利9221万元–1.08亿元 同比增长70%-100%",
    "href": "http://stock.jrj.com.cn/2020/03/29212729136854.shtml",
    "datetime": "2020-03-29 21:27:40",
    "code": "300759"
  },
  {
    "title": "康龙化成：一季度净利润预增70%-100%",
    "href": "http://stock.jrj.com.cn/2020/03/29184329136269.shtml",
    "datetime": "2020-03-29 18:43:00",
    "code": "300759"
  },
  {
    "title": "CXO企业维持高增长 疫情影响不改行业长期发展逻辑",
    "href": "http://stock.jrj.com.cn/2020/03/25230129109469.shtml",
    "datetime": "2020-03-25 23:01:32",
    "code": "300759"
  },
  {
    "title": "康龙化成股东北京多泰质押190万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2020/03/24211029097161.shtml",
    "datetime": "2020-03-24 21:10:44",
    "code": "300759"
  },
  {
    "title": "康龙化成2019年度盈利5.47亿增长64% 各业务板块收入和业务量增长",
    "href": "http://stock.jrj.com.cn/2020/02/28172128915561.shtml",
    "datetime": "2020-02-28 17:21:51",
    "code": "300759"
  },
  {
    "title": "康龙化成3名股东合计减持916万股 套现约4.91亿元",
    "href": "http://stock.jrj.com.cn/2020/02/19215428857813.shtml",
    "datetime": "2020-02-19 21:54:38",
    "code": "300759"
  },
  {
    "title": "康龙化成2名股东合计质押464.36万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2020/02/11201628811213.shtml",
    "datetime": "2020-02-11 20:16:33",
    "code": "300759"
  },
  {
    "title": "康龙化成向武汉红十字会捐赠三百万共抗疫情",
    "href": "http://stock.jrj.com.cn/2020/01/29182928741470.shtml",
    "datetime": "2020-01-29 18:29:00",
    "code": "300759"
  },
  {
    "title": "康龙化成3名股东拟减持股份 预计合计减持不超总股本2.99%",
    "href": "http://stock.jrj.com.cn/2020/01/22083028718347.shtml",
    "datetime": "2020-01-22 08:30:08",
    "code": "300759"
  },
  {
    "title": "康龙化成2019年度预计净利5.23亿元–5.56亿元 同比增长57%-67%",
    "href": "http://stock.jrj.com.cn/2020/01/21205628715198.shtml",
    "datetime": "2020-01-21 20:56:28",
    "code": "300759"
  },
  {
    "title": "康龙化成：三股东拟减持不超3%公司股份",
    "href": "http://stock.jrj.com.cn/2020/01/21173328714074.shtml",
    "datetime": "2020-01-21 17:33:59",
    "code": "300759"
  },
  {
    "title": "康龙化成：部分首次公开发行前已发行股份上市流通提示性公告",
    "href": "http://stock.jrj.com.cn/2020/01/20204028707909.shtml",
    "datetime": "2020-01-20 20:40:00",
    "code": "300759"
  },
  {
    "title": "康龙化成调入港股通股票名单",
    "href": "http://stock.jrj.com.cn/2019/12/23091928570643.shtml",
    "datetime": "2019-12-23 09:19:00",
    "code": "300759"
  },
  {
    "title": "午间公告：丽珠集团产品纳入医保目录；康龙化成H股挂牌交易",
    "href": "http://stock.jrj.com.cn/2019/11/28115628462593.shtml",
    "datetime": "2019-11-28 11:56:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成在香港联交所挂牌上市",
    "href": "http://stock.jrj.com.cn/2019/11/28000031456705.shtml",
    "datetime": "2019-11-28 00:00:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成与拜耳达成全球合作协议",
    "href": "http://stock.jrj.com.cn/2019/11/28000031456704.shtml",
    "datetime": "2019-11-28 00:00:00",
    "code": "300759"
  },
  {
    "title": "康龙化成龙虎榜：五家机构买入4367万元 四家机构卖出6877万元",
    "href": "http://stock.jrj.com.cn/2019/11/11165028380510.shtml",
    "datetime": "2019-11-11 16:50:00",
    "code": "300759"
  },
  {
    "title": "康龙化成发行H股获中国证监会核准",
    "href": "http://stock.jrj.com.cn/2019/10/29192628319742.shtml",
    "datetime": "2019-10-29 19:26:11",
    "code": "300759"
  },
  {
    "title": "康龙化成：获准发行不超1.34亿股境外上市外资股",
    "href": "http://stock.jrj.com.cn/2019/10/29182728319241.shtml",
    "datetime": "2019-10-29 18:27:55",
    "code": "300759"
  },
  {
    "title": "康龙化成：发行H股获中国证监会核准",
    "href": "http://stock.jrj.com.cn/2019/10/29182428319234.shtml",
    "datetime": "2019-10-29 18:24:00",
    "code": "300759"
  },
  {
    "title": "康龙化成第三季度盈利9.90亿 同比增长29%",
    "href": "http://stock.jrj.com.cn/2019/10/25222228302668.shtml",
    "datetime": "2019-10-25 22:22:58",
    "code": "300759"
  },
  {
    "title": "康龙化成2019前三季度净利约3.14亿–3.37亿 经营计划有序开展",
    "href": "http://stock.jrj.com.cn/2019/10/15095728248214.shtml",
    "datetime": "2019-10-15 09:57:21",
    "code": "300759"
  },
  {
    "title": "[康龙化成]第九届康龙化成有机合成与药物化学研讨会完美谢幕",
    "href": "http://stock.jrj.com.cn/2019/09/24000031456703.shtml",
    "datetime": "2019-09-24 00:00:00",
    "code": "300759"
  },
  {
    "title": "康龙化成发行H股申请材料获中国证监会受理",
    "href": "http://stock.jrj.com.cn/2019/08/26165828034005.shtml",
    "datetime": "2019-08-26 16:58:15",
    "code": "300759"
  },
  {
    "title": "康龙化成：发行H股申请材料获证监会受理",
    "href": "http://stock.jrj.com.cn/2019/08/26163128033864.shtml",
    "datetime": "2019-08-26 16:31:51",
    "code": "300759"
  },
  {
    "title": "康龙化成：发行H股申请材料获中国证监会受理",
    "href": "http://stock.jrj.com.cn/2019/08/26162828033859.shtml",
    "datetime": "2019-08-26 16:28:00",
    "code": "300759"
  },
  {
    "title": "康龙化成2019年上半年盈利1.6亿 收入规模不断扩大",
    "href": "http://stock.jrj.com.cn/2019/08/15183827982745.shtml",
    "datetime": "2019-08-15 18:38:10",
    "code": "300759"
  },
  {
    "title": "医药股集体走强：康龙化成等6股涨停 科创板微芯生物大涨17%",
    "href": "http://stock.jrj.com.cn/2019/08/14142427975318.shtml",
    "datetime": "2019-08-14 14:24:06",
    "code": "300759"
  },
  {
    "title": "康龙化成：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/13020027835079.shtml",
    "datetime": "2019-07-13 02:00:04",
    "code": "300759"
  },
  {
    "title": "康龙化成2019年上半年净利1.5亿–1.7亿 同比增长28%-43%",
    "href": "http://stock.jrj.com.cn/2019/07/12203427833872.shtml",
    "datetime": "2019-07-12 20:34:33",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成完成对联斯达的战略投资并与联斯达建立战略合作关系",
    "href": "http://stock.jrj.com.cn/2019/06/18000031456701.shtml",
    "datetime": "2019-06-18 00:00:00",
    "code": "300759"
  },
  {
    "title": "康龙化成去年净利3.39亿元 同比增长47% 董事长Boliang Lou年薪为291万元",
    "href": "http://stock.jrj.com.cn/2019/04/19073727426620.shtml",
    "datetime": "2019-04-19 07:37:59",
    "code": "300759"
  },
  {
    "title": "康龙化成:2018年净利同比增46.94％ 拟10派1.1元",
    "href": "http://stock.jrj.com.cn/2019/04/18185027423735.shtml",
    "datetime": "2019-04-18 18:50:00",
    "code": "300759"
  },
  {
    "title": "康龙化成：2018年净利同比增47% 拟10派1.1元",
    "href": "http://stock.jrj.com.cn/2019/04/18175827423437.shtml",
    "datetime": "2019-04-18 17:58:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成成功举办第二届生命科学化学研讨会",
    "href": "http://stock.jrj.com.cn/2019/03/06000031456697.shtml",
    "datetime": "2019-03-06 00:00:00",
    "code": "300759"
  },
  {
    "title": "康龙化成今天这个涨停板，你看懂了吗？",
    "href": "http://stock.jrj.com.cn/2019/02/27215127098938.shtml",
    "datetime": "2019-02-27 21:51:47",
    "code": "300759"
  },
  {
    "title": "新股提示：康龙化成开板 已收出13个涨停",
    "href": "http://stock.jrj.com.cn/2019/02/21093827069888.shtml",
    "datetime": "2019-02-21 09:38:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成于2019年1月28日在深交所挂牌上市",
    "href": "http://stock.jrj.com.cn/2019/01/28000031456700.shtml",
    "datetime": "2019-01-28 00:00:00",
    "code": "300759"
  },
  {
    "title": "【兑奖啦】康龙化成网上申购中签号出炉 共118134个",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/16201826915216.shtml",
    "datetime": "2019-01-16 20:18:13",
    "code": "300759"
  },
  {
    "title": "康龙化成将登陆A股：药明康德竞争对手 未来前景如何",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/16071126911148.shtml",
    "datetime": "2019-01-16 07:11:40",
    "code": "300759"
  },
  {
    "title": "康龙化成：网上发行中签率为0.0566471246％",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/15211626908444.shtml",
    "datetime": "2019-01-15 21:16:08",
    "code": "300759"
  },
  {
    "title": "康龙化成1月15日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/14151126901567.shtml",
    "datetime": "2019-01-14 15:11:36",
    "code": "300759"
  },
  {
    "title": "证监会：康龙化成、七彩化学首发获通过",
    "href": "http://stock.jrj.com.cn/ipo/2018/11/06200925311857.shtml",
    "datetime": "2018-11-06 20:09:02",
    "code": "300759"
  },
  {
    "title": "康龙化成IPO获通过：近三年毛利率约30% 低于A股同行",
    "href": "http://stock.jrj.com.cn/2018/11/06144125310628.shtml",
    "datetime": "2018-11-06 14:41:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]第八届康龙化成有机合成与药物化学研讨会完美谢幕",
    "href": "http://stock.jrj.com.cn/2018/09/19000031456699.shtml",
    "datetime": "2018-09-19 00:00:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成与南京思睿生物宣布签订投资协议 并建立战略合作关系",
    "href": "http://stock.jrj.com.cn/2018/05/18000031456698.shtml",
    "datetime": "2018-05-18 00:00:00",
    "code": "300759"
  },
  {
    "title": "康龙化成（北京）新药技术股份有限公司创业板首次公开发行股票招股说明书（申报稿2018年4月8日报送）",
    "href": "http://stock.jrj.com.cn/ipo/2018/04/13223024388977.shtml",
    "datetime": "2018-04-13 22:30:10",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成宁波新园区项目落成",
    "href": "http://stock.jrj.com.cn/2017/11/06000031456695.shtml",
    "datetime": "2017-11-06 00:00:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]第七届康龙化成有机合成与药物化学研讨会完美谢幕",
    "href": "http://stock.jrj.com.cn/2017/09/19000031456696.shtml",
    "datetime": "2017-09-19 00:00:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]Michael Rowley博士荣列ACS药物化学名人堂",
    "href": "http://stock.jrj.com.cn/2017/08/23000031456694.shtml",
    "datetime": "2017-08-23 00:00:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成成功举办英国霍兹登分部开业典礼 暨有机合成与药物化学研讨会",
    "href": "http://stock.jrj.com.cn/2017/02/13000031456691.shtml",
    "datetime": "2017-02-13 00:00:00",
    "code": "300759"
  },
  {
    "title": "[康龙化成]康龙化成收购美国Xceleron公司",
    "href": "http://stock.jrj.com.cn/2017/01/10000031456693.shtml",
    "datetime": "2017-01-10 00:00:00",
    "code": "300759"
  }
]